XSTREAM
Xerion Pharmaceuticals AG
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78237519 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Domestic Representative | Susan Freya Olive |
| Attorney Name | Susan Freya Olive |
| Attorney Docket Number | XEPA2400SOVJ |
| Law Office Assigned | L40 |
| Employee Name | SPILS, CAROL A |
Timeline
| 2003-03-03 | Date of First Use |
| 2003-04-14 | Application Filed |
| 2004-08-17 | Published for Opposition |
| 2006-01-23 | Abandon |
| 2006-02-17 | Location: TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED |
| 2006-02-17 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Xerion Pharmaceuticals AG |
| Address | Fraunhoferstrabe 9D-82152 Martinsried Martinsried DE |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | industrial product and scientific research, specifically, method for identification and production of therapeutics relating to the identification of ligands, namely, antibodies or antibody fragments that modulate the biological function of a particular target protein; scientific technological services, namely identification and production of therapeutics; industrial and scientific research, specifically method for identification and production of therapeutics relating to the identification of ligands, namely, antibodies or antibody fragments that modulate the biological function of a particular target protein; technological scientific research services, namely identification and production of therapeutics |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2003-10-19 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION E-MAILED | 2003-11-03 | 2 GNRT F:First Action |
| PAPER RECEIVED | 2004-04-27 | 3 MAIL I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-04-27 | 4 CRFA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2003-11-03 | 5 CRFA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2004-05-12 | 6 CNSA P: |
| NOTICE OF PUBLICATION | 2004-07-28 | 7 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2004-08-17 | 8 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2004-11-09 | 9 NOAM O:Outgoing Correspondence |
| FAX RECEIVED | 2005-01-14 | 10 FAXX I:Incoming Correspondence |
| USE AMENDMENT FILED | 2005-02-04 | 11 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2005-03-07 | 12 SUPC I:Incoming Correspondence |
| FAX RECEIVED | 2005-04-14 | 13 FAXX I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2005-07-22 | 14 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2005-07-22 | 15 GNRT O:Outgoing Correspondence |
| ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2006-02-17 | 16 ABN2 O:Outgoing Correspondence |
| ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2006-02-17 | 17 MAB2 O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 